Table 2.
Demographic, genotype distribution and treatment outcome of halitosis patients in the prospective study (n = 60)
| Characteristics | Genotypes | |||
|---|---|---|---|---|
| Non-AVI/AVI (n = 40) |
AVI/AVI (n = 20) |
P value | ||
| Demographic | Age, mean ± SD, y | 33.83 ± 6.64 | 35.90 ± 7.01 | 0.2757 a |
| Male sex, n (%) | 16 (40.0%) | 9 (45.0%) | 0.7111 b | |
| PPD (mm) | Baseline | 2.41 ± 0.47 | 2.57 ± 0.74 | 0.3076 a |
| 1-month | 1.84 ± 0.38 | 2.01 ± 0.50 | 0.2349 a | |
| 3-month | 1.88 ± 0.39 | 1.87 ± 0.46 | 0.9360a | |
| 6-month | 2.00 ± 0.52 | 2.09 ± 0.46 | 0.5520 a | |
| Treatment outcome | Improved | 27 | 2 | 0.0009 b |
| Persistent | 13 | 18 | ||
aunpaired student’s t test
bContinuity corrected chi-square test